Dataset
Apixaban; LC-ESI-QFT; MS2; CE: 60%; R=15000; [M+H]+
Chemical Information
| InChI | InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32) |
|---|---|
| SMILES | COC1=CC=C(C=C1)N2C3=C(CCN(C3=O)C4=CC=C(C=C4)N5CCCCC5=O)C(=N2)C(=O)N |
| InChI Key | QNZCBYKSOIHPEH-UHFFFAOYSA-N |
| Molecular Formula | C25H25N5O4 |
| Exact Mass | 459.191 g/mol |
Data and Resources
Metadata Information
| Field | Value |
|---|---|
| DOI | |
| License URL | https://creativecommons.org/licenses/by-sa/4.0 |
| Source | https://massbank.eu/MassBank/RecordDisplay?id=MSBNK-Eawag-EQ01104204 |
| Version | |
| Author | |
| Maintainer | |
| Language | |
| MetadataPublished | 2024-06-14 |
| Related Molecule |
|
| Field | Value |
|---|---|
| Measurement Technique | liquid chromatography-mass spectrometry |
| Measurement Variables |
| Data-Source Molecule ID | Data-Source |
|---|---|
| CHEMBL231779 | ChEMBL |
| 56310620 | PubChem: Drugs of the Future |
| GG2 | PDBe |
| APIXABAN | DailyMed |
| 19023 | BindingDB |
| APIXABAN | rxnorm |
| BMS-562247 | clinicaltrials |
| APIXABAN | clinicaltrials |
| ELIQUIS | clinicaltrials |
| HY-50667 | MedChemExpress |
| BMS-562247-01 | clinicaltrials |
| DTXSID80436500 | EPA CompTox Dashboard |
| 4298 | DrugCentral |
| 6390 | Guide to Pharmacology |
| J2.566.952E | Nikkaji |
| HMDB0248515 | Human Metabolome Database |
| NUPQEW | CCDC |
| ELIQUIS | rxnorm |
| 10182969 | PubChem |
| PD009294 | ProbesDrugs |
| 3Z9Y7UWC1J | FDA SRS |
| 503612-47-3 | ACToR |
| DB06605 | DrugBank |
| Apixaban(BMS-562247-01) | Selleck |
| 72296 | ChEBI |
| 15178464 | PubChem: Thomson Pharma |
| SCHEMBL118023 | SureChEMBL |
| 32278100 | eMolecules |
| LSM-45660 | LINCS |
| CB51508586 | ChemicalBook |
| 3564 | Brenda |
| ZINC000011677837 | ZINC |
| PA166163740 | PharmGKB |
| apixaban | DailyMed |
| 85842 | Brenda |
| The data in this table is sourced from UniChem at EBI. | |